blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2263659

EP2263659 - Contraceptive comprising folic acid [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.02.2015
Database last updated on 16.11.2024
Most recent event   Tooltip13.02.2015Application deemed to be withdrawnpublished on 18.03.2015  [2015/12]
Applicant(s)For all designated states
Richter Gedeon Nyrt.
Gyömröi út 19-21
1103 Budapest / HU
[2012/27]
Former [2010/51]For all designated states
Grünenthal GmbH
Zieglerstrasse 6
52078 Aachen / DE
Inventor(s)01 / Schramm, Georg, Dr.
Am Hügel 38
52224 Stolberg / DE
02 / Pâques, Eric-Paul, Prof. Dr.
Ronheider Berg 255
52076 Aachen / DE
 [2010/51]
Representative(s)Kutzenberger, Helga, et al
Kutzenberger Wolff & Partner
Waidmarkt 11
50676 Köln / DE
[N/P]
Former [2010/51]Kutzenberger, Helga, et al
Kutzenberger & Wolff Patentanwaltssozietät Theodor-Heuss-Ring 23
50668 Köln / DE
Application number, filing date10008750.127.05.2005
[2010/51]
Priority number, dateDE2004102667128.05.2004         Original published format: DE102004026671
DE2004102667028.05.2004         Original published format: DE102004026670
[2010/51]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP2263659
Date:22.12.2010
Language:DE
[2010/51]
Search report(s)(Supplementary) European search report - dispatched on:EP17.11.2010
ClassificationIPC:A61K9/36, A61K31/519, A61K31/565
[2010/51]
CPC:
A61K9/2866 (EP); A61K31/529 (EP); A61K31/565 (EP);
A61P15/18 (EP)
C-Set:
A61K31/529, A61K2300/00 (EP);
A61K31/565, A61K2300/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/51]
Extension statesLV20.06.2011
TitleGerman:Folsäurehaltiges Kontrazeptivum[2010/51]
English:Contraceptive comprising folic acid[2010/51]
French:Contraceptive comprenant de l'acide folique[2010/51]
Examination procedure20.06.2011Examination requested  [2011/31]
21.06.2011Amendment by applicant (claims and/or description)
04.04.2014Despatch of a communication from the examining division (Time limit: M06)
15.10.2014Application deemed to be withdrawn, date of legal effect  [2015/12]
11.11.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/12]
Parent application(s)   TooltipEP05750712.1  / EP1755562
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050750712) is  10.08.2009
Fees paidRenewal fee
23.12.2010Renewal fee patent year 03
23.12.2010Renewal fee patent year 04
23.12.2010Renewal fee patent year 05
23.12.2010Renewal fee patent year 06
11.05.2011Renewal fee patent year 07
29.03.2012Renewal fee patent year 08
27.05.2013Renewal fee patent year 09
13.03.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO9953910  (ORTHO MCNEIL PHARM INC [US], et al) [AD] 1-18 * example 13 * * claim 10 * * page 16, line 27 - page 17, line 7 *;
 [A]US2003050287  (WRIGHT JONATHAN V [US]) [A] 1-18 * claims 1-8 *;
 [A]GB888631  (UPJOHN CO) [A] 1-18 * example 5 * * page 5, column 2, line 35 - line 40 *;
 [A]  - MOOIJ P N ET AL, "Multivitamin supplementation in oral contraceptive users.", CONTRACEPTION. SEP 1991, (199109), vol. 44, no. 3, ISSN 0010-7824, pages 277 - 288, XP002339644 [A] 1-18 * page 278, paragraph LAST *

DOI:   http://dx.doi.org/10.1016/0010-7824(91)90018-B
by applicantWO9953910
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.